Cytokinetics Inc. buy The Goldman Sachs Group, Inc.
Start price
02.03.23
/
50%
€38.80
Target price
02.03.24
€45.28
Performance (%)
71.39%
End price
03.03.24
€66.50
Summary
This prediction ended on 03.03.24 with a price of €66.50. With a performance of 71.39% the BUY prediction by The_Goldman_Sachs_Gr was a big success. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cytokinetics Inc. | 1.463% | 1.463% | 104.294% | 119.079% |
| iShares Core DAX® | -1,06 % | 5,01 % | 6,60 % | 64,71 % |
| iShares Nasdaq 100 | -2,39 % | 0,86 % | 25,79 % | 88,24 % |
| iShares Nikkei 225® | -4,36 % | 1,21 % | 41,31 % | 79,31 % |
| iShares S&P 500 | -1,78 % | 1,39 % | 21,04 % | 69,60 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $56.00 to $48.00. They now have a "buy" rating on the stock.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten
Stopped prediction by The_Goldman_Sachs_Gr for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€31.60
09.11.23
09.11.23
€46.68
09.11.24
09.11.24
74.05%
10.11.24
10.11.24
